Our Perspectives

From Concept to Reality: Navigating to the Complexities of Medical Device Innovation

Beyond reviewing and approving drugs, the FDA plays a pivotal role in overseeing and approving medical devices, a realm defined by its innovation,...

Unlocking the Power of Systematic Literature Reviews in Your Value Communication Strategy

In today's fast-paced world, where information overload is the norm, the need for evidence-based decision-making has never been greater. Systematic...

From Rx to Over-the-Counter: Narcan's Role in Combating the Opioid Epidemic

The recent approval of Narcan as an over-the-counter drug is a landmark decision that has the potential to save thousands of lives and highlights the...

White House Initiative on Women’s Health Research

Despite decades of advancement in medical research, disparities in women’s health continue to impact patient outcomes and quality of life. The White...

Decoding Drug Pricing in the ERA of IRA: From Lab to Patients' Wallets

The journey from the research lab to a patient’s bedside for a drug is long, costly, and risky. Manufacturers make significant investments over many...

PCOS Awareness Month 2023: From Celebrity Revelations to AI Diagnosis

Empowered patients, better outcomes —

Navigating Women's Healthcare: A Look at the Current Landscape for Equality

Last Saturday, August 26, 2023, was Women's Equality Day, which commemorates the day in 1920 when women were finally granted the right to vote after...

From Crisis to Compassion: Bridging Mental Health Disparities in LGBTQIA+ Youth

Last week, we discussed Pride Month from the perspective of health equity in the LGBTQIA+ community. In our first Guest Blog post by Haylin Dennison,...

Unveiling the Rainbow: Addressing Health Disparities in the LGBTQIA+ Community During Pride Month

June is Pride Month, an annual observance dedicated to celebrating and advocating for the rights and inclusion of the LGBTQIA+ community. It is...

The Ongoing Journey to Access & Affordability: The Rise of PBMs, Evolution of GPOs, and FTC Inquiries

PBMs and GPOs are currently facing FTC inquiries into their business practices that impact drug pricing and access. This post reviews the nuances...

Communicating Value Across Stakeholders: Lessons from Peter Attia's "Outlive"

Let's face it, the healthcare landscape is complex - developing clear and concise value communication across stakeholders is essential.

Breaking Down the Inflation Reduction Act: How It's Shaking Up the Pharmaceutical Industry

Inflation affects nearly all goods and services on the market, including drugs and healthcare products. This is the first of a series of posts...